In The News
HepQuant and our liver disease experts have been featured in numerous news interviews and medical publications in recent years. The following is a partial list of news stories and articles in which we have been involved:
- Dec 2017 Greg Everson Retires After Pioneering Career | PDF Download
- 6/22/17 History of a Cure
- 2/11/16 Developing Tests to Assess Liver Function in NASH and Cirrhosis (Galectin Therapeutics CEO Perspectives)
- 2/11/16 Colorado OEDIT Grants $4.6M to Colorado Organizations (Colorado Bioscience Association)
- 10/16/15 HepQuant-STAT predicts HCV patients’ risk for clinical outcomes (Helio)
- 10/16/14 Everson awarded new patents for testing liver function (CU Connections)
- 10/9/14 Faculty members, research teams awarded patents (CU Connections)
- 4/23/14 Dr. Everson Interview on PBS